Cargando…

International heterogeneity in admission criteria and monitoring for the initiation of propranolol in infantile hemangioma

Detalles Bibliográficos
Autores principales:	Der Sarkissian, Samuel Antranig, Wargon, Orli, Sebaratnam, Deshan Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361929/ https://www.ncbi.nlm.nih.gov/pubmed/34409330 http://dx.doi.org/10.1016/j.jdin.2020.06.005

Ejemplares similares

Commentary: Propranolol for infantile hemangiomas — The intralesional route
por: Tripathy, Devjyoti
Publicado: (2019)

A transcription factor is the target of propranolol treatment in infantile hemangioma
por: Schrenk, Sandra, et al.
Publicado: (2022)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Recommendations on dermatologic surgery during the COVID-19 pandemic
por: Der Sarkissian, Samuel Antranig, et al.
Publicado: (2020)

Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)

Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)

Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015)

When to stop propranolol for infantile hemangioma
por: Chang, Lei, et al.
Publicado: (2017)

Our experience with propranolol for infantile hemangioma
por: Wu, Yao, et al.
Publicado: (2023)

Therapeutic Effect of Propranolol in Mexican Patients with Infantile Hemangioma
por: Castaneda, Saul, et al.
Publicado: (2015)

Variable Response to Propranolol Therapy for Infantile Hemangiomas
por: Jain, Vishesh, et al.
Publicado: (2012)

Excellent response of infantile orbital hemangioma to propranolol
por: Sendrasoa, Fandresena A, et al.
Publicado: (2016)

Propranolol: Effectiveness and Failure in Infantile Cutaneous Hemangiomas
por: Praticò, Andrea Domenico, et al.
Publicado: (2015)

Propranolol therapy for infantile hemangioma: our experience
por: Zhang, Ling, et al.
Publicado: (2017)

Propranolol-induced hyperkalemia in the management of infantile hemangioma
por: Al-Rwebah, Huda, et al.
Publicado: (2020)

Severe hypoglycemia in propranolol treatment for infantile hemangiomas
por: Morimoto, Akira, et al.
Publicado: (2022)

The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol
por: Castaneda, Saul, et al.
Publicado: (2016)

Multiple Infantile Hemangiomas Treated Successfully with Oral Propranolol
por: Purkait, Radheshyam, et al.
Publicado: (2016)

Neonatal Abdominal Hemangiomatosis: Propranolol beyond Infantile Hemangioma
por: Nip, Siu Ying Angel, et al.
Publicado: (2016)

Induction of apoptosis in infantile hemangioma endothelial cells by propranolol
por: TU, JUN-BO, et al.
Publicado: (2013)

Oral propranolol therapy in 23 infants with infantile hemangioma
por: Kim, Jaeyoon, et al.
Publicado: (2018)

Infantile Hemangioma Treated with Oral Propranolol: Case Presentation
por: Raufi, Nahid, et al.
Publicado: (2021)

Management of infantile subglottic hemangioma with T-tube placement and propranolol
por: D’Ambrosio, Paula Duarte, et al.
Publicado: (2022)

Early propranolol treatment of infantile hemangiomas improves outcome()
por: Giachetti, Ana, et al.
Publicado: (2023)

A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas
por: Zhao, Ze-Liang, et al.
Publicado: (2021)

Management of Infantile Hemangiomas
por: Reddy, Kavitha K
Publicado: (2014)

Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children
por: Hassan, Basheir A., et al.
Publicado: (2014)

Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro
por: ZHU, YALIN, et al.
Publicado: (2014)

Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence
por: Xiao, Qiang, et al.
Publicado: (2013)

Oral Propranolol in Infantile Hemangiomas: Analysis of Factors that Affect the Outcome
por: Ainipully, Arun Mohanan, et al.
Publicado: (2019)

Deep coma in a child treated with propranolol for infantile hemangioma
por: Bakalli, Ilirjana, et al.
Publicado: (2019)

Dermoscopic features of infantile hemangioma during treatment with topical propranolol
por: Valdebran, Manuel, et al.
Publicado: (2020)

Propranolol-induced hyperkalemia in infantile hemangioma patients: How serious is it?
por: Alakeel, Abduallah, et al.
Publicado: (2022)

Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis
por: STILES, JESSICA, et al.
Publicado: (2012)

Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas
por: Lou, Huanmin, et al.
Publicado: (2018)

Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma
por: Takechi, Tomoki, et al.
Publicado: (2018)

Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
por: Wu, Hai Wei, et al.
Publicado: (2018)

Efficacy of infantile hepatic hemangioma with propranolol treatment: A case report
por: Tsai, Mu-Chieh, et al.
Publicado: (2019)

Propranolol for Treatment of Infantile Hemangioma: Efficacy and Effect on Pediatric Growth and Development
por: Giese, Rachel A., et al.
Publicado: (2021)

Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
por: Phillips, James D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ff8e6vk487nb4g54ctl66qb582